Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 22-25 January 2024
Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 22-25 January 2024
Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 22-25 January 2024
Sixth EMA-Medicines for Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 6 December 2023
Enpr-EMA newsletter 2023
Production API and registration process - production release version 01.6.42 - Veterinary Medicinal Products Regulation: Union Product Database
First European Medicines Agency (EMA) and IPFA – PPTA bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 8 December 2023
List of eligible industry stakeholder organisations
Human medicines European public assessment report (EPAR): Actraphane, insulin human (rDNA), Date of authorisation: 07/10/2002, Revision: 20, Status: Authorised
Records of data processing activity (public) for the Antimicrobials Sales and Use (ASU) platform
European Medicines Agency’s Data Protection Notice for the Antimicrobials Sales and Use platform
EVVet3 EVWeb Production – Release notes